{
    "clinical_study": {
        "@rank": "83954", 
        "arm_group": [
            {
                "arm_group_label": "Unilateral stent insertion group", 
                "arm_group_type": "Active Comparator", 
                "description": "the use of unilateral stent insertion in malignant hilar obstruction for using endoscopic retrograde cholangiopancreatography(ERCP)"
            }, 
            {
                "arm_group_label": "Bilateral stent insertion group", 
                "arm_group_type": "Active Comparator", 
                "description": "the use of bilateral stent insertion in malignant hilar obstruction for using endoscopic retrograde cholangiopancreatography(ERCP)"
            }
        ], 
        "brief_summary": {
            "textblock": "Internal biliary drainage is an useful method for a control of jaundice and cholangitis to\n      patients who had a malignant hilar obstruction due to hepatocellular carcinoma,\n      cholangiocarcinoma, gall bladder cancer or metastatic lymphadenopathy.\n\n      Bilateral biliary drainage is more physiologic but technically difficult to compared with\n      unilateral biliary drainage specially related to conformability and flexibility between\n      using stents.\n\n      There are no prospective clinical trials compared with these internal biliary drainage\n      methods in hilar malignant obstruction using metal stent.\n\n      Therefore, the investigators want to compare the clinical outcome of two method: Unilateral\n      biliary stent and Bilateral biliary stent"
        }, 
        "brief_title": "Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD Stent", 
        "completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Obstruction of Biliary Tree", 
            "Cholangiocarcinoma", 
            "Hepatocellular Carcinoma", 
            "Malignant Lymphadenopathy", 
            "Gall Bladder Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Urinary Bladder Neoplasms", 
                "Carcinoma", 
                "Gallbladder Neoplasms", 
                "Cholangiocarcinoma", 
                "Lymphatic Diseases", 
                "Carcinoma, Hepatocellular"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age> 18\n\n          -  diagnosis of malignancy in pathology or cytology\n\n          -  jaundice(Total bilirubin)> 2.0 mg/dL\n\n          -  Diagnosed malignant hilar invasion to CT or other image finding\n\n        Exclusion Criteria:\n\n          -  bleeding tendency(INR>1.5)\n\n          -  Pregnancy\n\n          -  severe liver,kidney disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "42", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01875549", 
            "org_study_id": "2013-03-014-002"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Unilateral stent insertion group", 
                    "Bilateral stent insertion group"
                ], 
                "description": "to use a LCD stent at an unilateral or bilateral stent insertion", 
                "intervention_name": "stent insertion", 
                "intervention_type": "Device", 
                "other_name": "Niti-S large cell D-type biliary stent [LCD]"
            }, 
            {
                "arm_group_label": [
                    "Unilateral stent insertion group", 
                    "Bilateral stent insertion group"
                ], 
                "description": "to use ERCP for a stent insertion in an obstructive biliary tract", 
                "intervention_name": "Endoscopic retrograde cholangiopancreatoscopy(ERCP)", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 11, 2013", 
        "number_of_arms": "2", 
        "official_title": "Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a Large Cell Niti-S (LCD) Stent", 
        "other_outcome": {
            "description": "Participants will followed after stent insertion and observe a complication rate between two groups.", 
            "measure": "complication", 
            "safety_issue": "Yes", 
            "time_frame": "up to 1year"
        }, 
        "overall_official": {
            "affiliation": "Division of Gastroenterology,Department of internal medicaion,samsung medical center,Sungkyunkwan University School of Medicine", 
            "last_name": "Kwang hyuck Lee, PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Participants will followed for the new obstruction(new jaundice) will occur.", 
            "measure": "Stent patency", 
            "safety_issue": "Yes", 
            "time_frame": "up to 1year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01875549"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Samsung Medical Center", 
            "investigator_full_name": "Kwang Hyuck Lee", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "Participants will followed for 1year.", 
            "measure": "survival period", 
            "safety_issue": "Yes", 
            "time_frame": "up to 1year"
        }, 
        "source": "Samsung Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Kwang Hyuck Lee", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}